Cardiovascular Systems, Inc. Release: Mount Sinai Cardiologist First in the United States to Use CSI’s Revolutionary New Technology to Treat Coronary Artery Disease

Published: Oct 28, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that Samin K. Sharma, M.D., Director of Clinical and Interventional Cardiology at The Mount Sinai Medical Center, New York, N.Y., is the first physician in the United States to treat severely calcified coronary lesions using the revolutionary, new Diamondback 360® Coronary Orbital Atherectomy System (OAS). The Diamondback 360 Coronary OAS uses a patented combination of differential sanding and centrifugal force to reduce arterial calcium that can cause complications when treating coronary artery disease (CAD). The system gained U.S. Food and Drug Administration (FDA) approval on October 21, 2013, and is the first and only technology approved for the treatment of severely calcified coronary lesions.

Help employers find you! Check out all the jobs and post your resume.

Back to news